ALPMY

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)

About ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Details

Daily high
$13.87
Daily low
$12.83
Price at open
$13.87
52 Week High
$13.92
52 Week Low
$8.37
Market cap
24.1B
Dividend yield
3.78%
Volume
122,009
Avg. volume
125,132
P/E ratio
27.97

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. News

Details

Daily high
$13.87
Daily low
$12.83
Price at open
$13.87
52 Week High
$13.92
52 Week Low
$8.37
Market cap
24.1B
Dividend yield
3.78%
Volume
122,009
Avg. volume
125,132
P/E ratio
27.97